Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Aug-21 7:38 PM View:  | Surrozen, Inc./de (SRZN) | 11-Aug-21 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 19-Feb-19 5:08 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Feb-19 | Market Sale (Planned) | 775 | $39.59 | $30,682.20 | (< 1%) 292.72K to 291.94K | 43% |
| 11-Feb-19 7:10 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 11-Feb-19 | Market Sale (Planned) | 13,975 | $38.55 | $538,736.00 | (5%) 306.69K to 292.72K | 41% |
| 08-Feb-19 4:28 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 06-Feb-19 | Grant | 15,000 | -- | -- | 5% 305.58K to 320.58K | |
| 08-Feb-19 4:28 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 06-Feb-19 | Payment of Exercise | 1,512 | $38.47 | $58,166.60 | (< 1%) 320.58K to 319.07K | 41% |
| 08-Feb-19 4:28 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 06-Feb-19 | Market Sale (Planned) | 12,375 | $38.62 | $477,922.00 | (4%) 319.07K to 306.69K | 42% |
| 15-Nov-18 4:53 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Nov-18 | Market Sale (Planned) | 775 | $33.81 | $26,202.80 | (< 1%) 306.36K to 305.58K | 33% |
| 27-Sep-18 4:56 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 26-Sep-18 | Market Sale (Planned) | 13,500 | $43.08 | $581,580.00 | (4%) 319.86K to 306.36K | 48% |
| 25-Sep-18 5:02 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 25-Sep-18 | Market Sale (Planned) | 13,500 | $40.51 | $546,905.00 | (4%) 333.36K to 319.86K | 44% |
| 25-Sep-18 5:02 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 24-Sep-18 | Market Sale (Planned) | 18,000 | $39.91 | $718,426.00 | (5%) 351.36K to 333.36K | 43% |
| 16-Aug-18 5:12 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Aug-18 | Market Sale (Planned) | 775 | $37.54 | $29,093.50 | (< 1%) 352.13K to 351.36K | 40% |
| 16-May-18 8:37 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-May-18 | Option Exercise | 25,000 | $11.00 | $275,000.00 | 7% 352.9K to 377.9K | |
| 16-May-18 8:37 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-May-18 | Market Option Sale (Planned) | 25,000 | $45.30 | $1,132,380.00 | (7%) 377.9K to 352.9K | 50% |
| 16-May-18 8:37 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-May-18 | Market Sale (Planned) | 775 | $45.30 | $35,103.70 | (< 1%) 352.9K to 352.13K | 50% |
| 27-Mar-18 4:16 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 26-Mar-18 | Market Sale (Planned) | 18,327 | $39.79 | $729,264.00 | (5%) 371.23K to 352.9K | 43% |
| 20-Feb-18 8:24 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Feb-18 | Option Exercise | 553 | -- | -- | < 1% 370.68K to 371.23K | |
| 12-Feb-18 8:55 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 09-Feb-18 | Payment of Exercise | 4,925 | $41.70 | $205,372.00 | (1%) 375.6K to 370.68K | 46% |
| 08-Feb-18 5:46 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 06-Feb-18 | Grant | 17,500 | -- | -- | 5% 362.53K to 380.03K | |
| 08-Feb-18 5:46 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 06-Feb-18 | Payment of Exercise | 4,426 | $35.80 | $158,451.00 | (1%) 380.03K to 375.6K | 37% |
| 17-Nov-17 6:27 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Nov-17 | Option Exercise | 829 | -- | -- | < 1% 363.31K to 364.13K | |
| 17-Nov-17 6:27 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Nov-17 | Market Option Sale (Planned) | 829 | $13.36 | $11,075.40 | (< 1%) 364.13K to 363.31K | (69%) |
| 17-Nov-17 6:27 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Nov-17 | Market Sale (Planned) | 775 | $13.36 | $10,354.00 | (< 1%) 363.31K to 362.53K | (69%) |
| 17-Oct-17 4:46 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Oct-17 | Market Sale (Planned) | 6,000 | $14.35 | $86,100.00 | (2%) 369.31K to 363.31K | (57%) |
| 18-Sep-17 5:46 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Sep-17 | Market Sale (Planned) | 6,000 | $15.30 | $91,800.00 | (2%) 375.31K to 369.31K | (47%) |
| 17-Aug-17 5:35 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Aug-17 | Option Exercise | 829 | -- | -- | < 1% 382.08K to 382.91K | |
| 17-Aug-17 5:35 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Aug-17 | Market Option Sale (Planned) | 829 | $14.75 | $12,227.80 | (< 1%) 382.91K to 382.08K | (53%) |
| 17-Aug-17 5:35 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Aug-17 | Market Sale (Planned) | 6,775 | $14.75 | $99,931.20 | (2%) 382.08K to 375.31K | (53%) |
| 18-Jul-17 4:24 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-Jul-17 | Market Sale (Planned) | 6,000 | $14.92 | $89,520.00 | (2%) 388.08K to 382.08K | (51%) |
| 16-Jun-17 4:47 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Jun-17 | Market Sale (Planned) | 6,000 | $12.65 | $75,900.00 | (2%) 394.08K to 388.08K | (78%) |
| 17-May-17 4:58 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-May-17 | Option Exercise | 829 | -- | -- | < 1% 400.86K to 401.68K | |
| 17-May-17 4:58 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-May-17 | Market Option Sale (Planned) | 829 | $14.99 | $12,426.70 | (< 1%) 401.68K to 400.86K | (51%) |
| 17-May-17 4:58 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-May-17 | Market Sale (Planned) | 6,775 | $14.99 | $101,557.00 | (2%) 400.86K to 394.08K | (51%) |
| 19-Apr-17 4:29 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-Apr-17 | Market Sale (Planned) | 6,000 | $17.28 | $103,680.00 | (1%) 406.86K to 400.86K | (31%) |
| 17-Mar-17 5:07 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Mar-17 | Market Sale (Planned) | 6,000 | $19.60 | $117,600.00 | (1%) 412.86K to 406.86K | (15%) |
| 16-Feb-17 8:08 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Feb-17 | Option Exercise | 829 | -- | -- | < 1% 419.63K to 420.46K | |
| 16-Feb-17 8:08 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Feb-17 | Market Option Sale (Planned) | 829 | $15.49 | $12,841.20 | (< 1%) 420.46K to 419.63K | (46%) |
| 16-Feb-17 8:08 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Feb-17 | Market Sale (Planned) | 6,775 | $15.49 | $104,945.00 | (2%) 419.63K to 412.86K | (46%) |
| 10-Feb-17 6:23 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 09-Feb-17 | Market Sale (Planned) | 13,975 | $15.46 | $216,054.00 | (3%) 433.61K to 419.63K | (46%) |
| 08-Feb-17 5:37 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 06-Feb-17 | Grant | 49,500 | -- | -- | 13% 384.11K to 433.61K | |
| 18-Jan-17 7:52 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-Jan-17 | Market Sale (Planned) | 6,000 | $14.27 | $85,620.00 | (2%) 390.11K to 384.11K | (58%) |
| 15-Dec-16 7:28 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Dec-16 | Market Sale (Planned) | 6,000 | $15.40 | $92,400.00 | (2%) 396.11K to 390.11K | (46%) |
| 22-Nov-16 6:40 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 21-Nov-16 | Market Sale (Planned) | 7,068 | $17.85 | $126,164.00 | (2%) 403.17K to 396.11K | (26%) |
| 17-Nov-16 4:53 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Nov-16 | Option Exercise | 829 | -- | -- | < 1% 403.95K to 404.78K | |
| 17-Nov-16 4:53 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Nov-16 | Market Option Sale (Planned) | 829 | $19.95 | $16,538.60 | (< 1%) 404.78K to 403.95K | (13%) |
| 17-Nov-16 4:53 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Nov-16 | Market Sale (Planned) | 775 | $19.95 | $15,461.30 | (< 1%) 403.95K to 403.17K | (13%) |
| 23-Sep-16 7:26 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 22-Sep-16 | Grant | 90,000 | -- | -- | 29% 313.95K to 403.95K | |
| 17-Aug-16 7:47 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Aug-16 | Option Exercise | 829 | -- | -- | < 1% 314.46K to 315.29K | |
| 17-Aug-16 7:47 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Aug-16 | Market Option Sale (Planned) | 829 | $22.32 | $18,502.00 | (< 1%) 315.29K to 314.46K | (1%) |
| 17-Aug-16 7:47 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Aug-16 | Market Sale (Planned) | 517 | $22.32 | $11,538.70 | (< 1%) 314.46K to 313.95K | (1%) |
| 18-May-16 7:05 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-May-16 | Option Exercise | 830 | -- | -- | < 1% 315.24K to 316.07K |